The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

今年的STS竞赛，共有超过 2600名学生提交申请，他们来自46个州、华盛顿特区、北马里亚纳群岛、波多黎各以及全球16个国家的826所高中。经过激烈角逐，最终有300位年轻人脱颖而出，入选本届学者名单—— ...

Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

Oregon Ridge Park in Cockeysville is the escape hatch you never knew you needed – a sprawling natural sanctuary just a short drive from Baltimore’s urban hustle. Have you ever discovered something so ...